Relationship of cardiac chamber volume to baroreflex activity in normal humans. 1987

E G Nabel, and W S Colucci, and L S Lilly, and S S Cutler, and J A Majzoub, and M G St John Sutton, and V J Dzau, and M A Creager

The objectives of this study were to examine the effect of incremental lower body negative pressure (LBNP) on cardiac chamber volume and assess the relationship between cardiac chamber volume and baroreflex activation of the neurohormonal axis. Accordingly, echocardiographic determination of cardiac chamber volume and neurohormonal responses were studied in 14 normal subjects during incremental LBNP. LBNP -10 mm Hg decreased left atrial diameter and left ventricular systolic volume index, but did not alter heart rate, systolic or pulse pressure, or stroke volume. During LBNP -10 mm Hg, plasma norepinephrine levels increased, suggesting activation of the sympathetic nervous system. LBNP -40 mm Hg caused a significant decrease in left atrial diameter and left ventricular systolic, diastolic, and stroke volume indices. During LBNP -40 mm Hg, heart rate increased, and systolic and pulse pressure fell. With this more negative level of LBNP, norepinephrine, angiotensin II, aldosterone, and arginine vasopressin concentrations and PRA all increased. The findings that left atrial diameter decreased and plasma norepinephrine concentration increased during LBNP -10 mm Hg suggest that the sympathetic nervous system is sensitive to changes in atrial receptor activity. At higher levels of LBNP (-40 mm Hg), activation of the renin-angiotensin system and release of vasopressin were associated with a fall in left ventricular diastolic volume as well as a decrease in the pressure input to the arterial baroreceptors. Under this condition, the differential contribution of the cardiopulmonary and arterial baroreceptors to the regulation of the renin-angiotensin system and vasopressin release cannot be distinguished.

UI MeSH Term Description Entries
D008150 Lower Body Negative Pressure External decompression applied to the lower body. It is used to study orthostatic intolerance and the effects of gravitation and acceleration, to produce simulated hemorrhage in physiologic research, to assess cardiovascular function, and to reduce abdominal stress during childbirth. Abdominal Decompression,Decompression, Abdominal,LBNP
D008297 Male Males
D011311 Pressoreceptors Receptors in the vascular system, particularly the aorta and carotid sinus, which are sensitive to stretch of the vessel walls. Baroreceptors,Receptors, Stretch, Arterial,Receptors, Stretch, Vascular,Stretch Receptors, Arterial,Stretch Receptors, Vascular,Arterial Stretch Receptor,Arterial Stretch Receptors,Baroreceptor,Pressoreceptor,Receptor, Arterial Stretch,Receptor, Vascular Stretch,Receptors, Arterial Stretch,Receptors, Vascular Stretch,Stretch Receptor, Arterial,Stretch Receptor, Vascular,Vascular Stretch Receptor,Vascular Stretch Receptors
D012018 Reflex An involuntary movement or exercise of function in a part, excited in response to a stimulus applied to the periphery and transmitted to the brain or spinal cord.
D012084 Renin-Angiotensin System A BLOOD PRESSURE regulating system of interacting components that include RENIN; ANGIOTENSINOGEN; ANGIOTENSIN CONVERTING ENZYME; ANGIOTENSIN I; ANGIOTENSIN II; and angiotensinase. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming ANGIOTENSIN I. Angiotensin-converting enzyme, contained in the lung, acts on angiotensin I in the plasma converting it to ANGIOTENSIN II, an extremely powerful vasoconstrictor. Angiotensin II causes contraction of the arteriolar and renal VASCULAR SMOOTH MUSCLE, leading to retention of salt and water in the KIDNEY and increased arterial blood pressure. In addition, angiotensin II stimulates the release of ALDOSTERONE from the ADRENAL CORTEX, which in turn also increases salt and water retention in the kidney. Angiotensin-converting enzyme also breaks down BRADYKININ, a powerful vasodilator and component of the KALLIKREIN-KININ SYSTEM. Renin-Angiotensin-Aldosterone System,Renin Angiotensin Aldosterone System,Renin Angiotensin System,System, Renin-Angiotensin,System, Renin-Angiotensin-Aldosterone
D002306 Cardiac Volume The volume of the HEART, usually relating to the volume of BLOOD contained within it at various periods of the cardiac cycle. The amount of blood ejected from a ventricle at each beat is STROKE VOLUME. Heart Volume,Cardiac Volumes,Heart Volumes,Volume, Cardiac,Volume, Heart,Volumes, Cardiac,Volumes, Heart
D004452 Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Echocardiography, Contrast,Echocardiography, Cross-Sectional,Echocardiography, M-Mode,Echocardiography, Transthoracic,Echocardiography, Two-Dimensional,Transthoracic Echocardiography,2-D Echocardiography,2D Echocardiography,Contrast Echocardiography,Cross-Sectional Echocardiography,Echocardiography, 2-D,Echocardiography, 2D,M-Mode Echocardiography,Two-Dimensional Echocardiography,2 D Echocardiography,Cross Sectional Echocardiography,Echocardiography, 2 D,Echocardiography, Cross Sectional,Echocardiography, M Mode,Echocardiography, Two Dimensional,M Mode Echocardiography,Two Dimensional Echocardiography
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

E G Nabel, and W S Colucci, and L S Lilly, and S S Cutler, and J A Majzoub, and M G St John Sutton, and V J Dzau, and M A Creager
October 1990, The American journal of physiology,
E G Nabel, and W S Colucci, and L S Lilly, and S S Cutler, and J A Majzoub, and M G St John Sutton, and V J Dzau, and M A Creager
October 1993, The American journal of physiology,
E G Nabel, and W S Colucci, and L S Lilly, and S S Cutler, and J A Majzoub, and M G St John Sutton, and V J Dzau, and M A Creager
July 2007, Obesity (Silver Spring, Md.),
E G Nabel, and W S Colucci, and L S Lilly, and S S Cutler, and J A Majzoub, and M G St John Sutton, and V J Dzau, and M A Creager
December 2010, Hypertension (Dallas, Tex. : 1979),
E G Nabel, and W S Colucci, and L S Lilly, and S S Cutler, and J A Majzoub, and M G St John Sutton, and V J Dzau, and M A Creager
September 1995, American journal of hypertension,
E G Nabel, and W S Colucci, and L S Lilly, and S S Cutler, and J A Majzoub, and M G St John Sutton, and V J Dzau, and M A Creager
September 2012, Journal of hypertension,
E G Nabel, and W S Colucci, and L S Lilly, and S S Cutler, and J A Majzoub, and M G St John Sutton, and V J Dzau, and M A Creager
May 1987, Circulation,
E G Nabel, and W S Colucci, and L S Lilly, and S S Cutler, and J A Majzoub, and M G St John Sutton, and V J Dzau, and M A Creager
November 1990, Clinical pharmacology and therapeutics,
E G Nabel, and W S Colucci, and L S Lilly, and S S Cutler, and J A Majzoub, and M G St John Sutton, and V J Dzau, and M A Creager
January 1992, Circulation research,
E G Nabel, and W S Colucci, and L S Lilly, and S S Cutler, and J A Majzoub, and M G St John Sutton, and V J Dzau, and M A Creager
December 1991, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
Copied contents to your clipboard!